Stay updated on Zephyrus II Pamrevlumab Clinical Trial
Sign up to get notified when there's something new on the Zephyrus II Pamrevlumab Clinical Trial page.

Latest updates to the Zephyrus II Pamrevlumab Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 is now shown. The government-funding notice and the previous Revision: v3.4.1 have been removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAn administrative funding notice was added and the site revision updated to v3.4.1 (replacing v3.4.0); to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedFooter updates: Show glossary option added, No FEAR Act Data link added, and the revision updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedSponsor changed from FibroGen to Kyntra Bio in the study record.SummaryDifference0.3%

- Check62 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing v3.3.3; this is a minor site update and does not modify study data, endpoints, eligibility criteria, or recruitment information.SummaryDifference0.1%

Stay in the know with updates to Zephyrus II Pamrevlumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zephyrus II Pamrevlumab Clinical Trial page.